2017 Section 7 Green Book

FIGURE 3. Duration of response for all

patients with a response per endpoint

assessment committee (EAC) was cen-

sored (marked by arrow) if at the last

tumor assessment there was no evi-

dence (per EAC) that the response had

ended. Probability of being in response

was estimated using the Kaplan–Meier

method. Because only 1 patient in the

granulocyte-macrophage colony-stim-

ulating factor (GM-CSF) group had a

response lasting

3 months, probabil-

ity of being in response was not calcu-

lated for this group.

FIGURE 4. (A) Time to treatment failure per investigator assessment. (B) Overall survival. CI, confidence interval; GM-CSF, granulocyte-macrophage

colony-stimulating factor; IQR, interquartile range; NE, not estimable; OS, overall survival.

NCOLYTIC IMMUNOTHERAPY IN CUTANEOUS HEAD AND NECK MELANOMA

HEAD & NECK—DOI

10.1002/hed

172